Literature DB >> 21765264

Brain tumor rehabilitation.

Mary Vargo1.   

Abstract

Brain and other central nervous system tumors have a very high likelihood of producing long-term disabling effects owing to the tumor itself and the effects of treatment, including surgical complications, neurotoxic effects of radiation, and debility caused by chemotherapy. Even benign or low-grade brain tumors can cause significant disability. Brain tumors occur over the life span, showing progressively higher incidence with advancing age. The common types of primary brain tumor differ between pediatric and adult age groups. Evidence for effectiveness of rehabilitation is favorable. Brain tumor patients treated in acute rehabilitation settings improve comparably with individuals with stroke or traumatic brain injury. Although patients with primary brain tumors have been better studied than those with metastatic disease, significant gains with inpatient rehabilitation have been reported in the latter group also. Outpatient programs to address cognitive deficits in brain tumor survivors, including cognitive therapy and pharmacologic strategies, have found benefit. While the patient is receiving rehabilitation care, physiatrists, in interdisciplinary collaboration with the pertinent oncology-related services, assist with managing symptoms including fatigue, headache, and sleep disturbance and medical complications including depression, seizures, and thromboembolic disease. Better methods are needed to identify patients for rehabilitation services when appropriate over the course of the disease process.

Entities:  

Mesh:

Year:  2011        PMID: 21765264     DOI: 10.1097/PHM.0b013e31820be31f

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


  24 in total

Review 1.  Guidelines for Treatment and Monitoring of Adult Survivors of Pediatric Brain Tumors.

Authors:  Anna J Janss; Claire Mazewski; Briana Patterson
Journal:  Curr Treat Options Oncol       Date:  2019-02-09

2.  Factors associated with long-term functional outcomes, psychological sequelae and quality of life in persons after primary brain tumour.

Authors:  Fary Khan; Bhasker Amatya
Journal:  J Neurooncol       Date:  2013-01-05       Impact factor: 4.130

3.  Cancer rehabilitation: a barometer for survival?

Authors:  Takako Saotome; Linda Klein; Steven Faux
Journal:  Support Care Cancer       Date:  2015-03-05       Impact factor: 3.603

4.  Prevalence, correlates, and impact of sleep disturbance in Chinese meningioma patients.

Authors:  Dandan Zhang; Jing Wang; Xixi Gu; Zhifeng Gu; Liren Li; Chen Dong; Rui Zhao; Xiaomei Zhang
Journal:  Support Care Cancer       Date:  2021-08-30       Impact factor: 3.359

Review 5.  Posterior Fossa Tumor Rehabilitation: An Up-to-Date Overview.

Authors:  Daniela Pia Rosaria Chieffo; Federica Lino; Valentina Arcangeli; Federica Moriconi; Paolo Frassanito; Luca Massimi; Gianpiero Tamburrini
Journal:  Children (Basel)       Date:  2022-06-16

6.  Comparison of swallowing functions between brain tumor and stroke patients.

Authors:  Dae Hwan Park; Min Ho Chun; Sook Joung Lee; Yoon Bum Song
Journal:  Ann Rehabil Med       Date:  2013-10-29

7.  Treatment options in newly diagnosed glioblastoma.

Authors:  Eudocia Q Lee; Lakshmi Nayak; Patrick Y Wen; David A Reardon
Journal:  Curr Treat Options Neurol       Date:  2013-06       Impact factor: 3.598

Review 8.  Improving Care in Pediatric Neuro-oncology Patients: An Overview of the Unique Needs of Children With Brain Tumors.

Authors:  Cheryl Fischer; Mary Petriccione; Maria Donzelli; Elaine Pottenger
Journal:  J Child Neurol       Date:  2015-08-05       Impact factor: 1.987

Review 9.  Seizures in children with dysembryoplastic neuroepithelial tumors of the brain--A review of surgical outcomes across several studies.

Authors:  Adrianna Ranger; David Diosy
Journal:  Childs Nerv Syst       Date:  2015-03-21       Impact factor: 1.475

Review 10.  Multidisciplinary rehabilitation after primary brain tumour treatment.

Authors:  Fary Khan; Bhasker Amatya; Louisa Ng; Kate Drummond; Mary Galea
Journal:  Cochrane Database Syst Rev       Date:  2015-08-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.